Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
6α-Methylprednisolone 21-acetate is a synthetic glucocorticoid and an ester form of methylprednisolone (Item No. 15013).1 It reduces IL-1β-induced production of prostaglandin E2 (PGE2; Item No. 14010) and increases in matrix metalloproteinase-13 (MMP-13) levels in equine osteochondral and synovial explant cocultures when used at concentrations ranging from 1 to 100 nM. Intramuscular injection of 6α-methylprednisolone 21-acetate (20 mg/kg) induces retinal lipid peroxidation and apoptosis in rabbits.2 Formulations containing 6α-methylprednisolone 21-acetate have been used in the treatment of joint pain and swelling associated with arthritis.
WARNING This product is not for human or veterinary use.
1. In vitro effects of three equimolar concentrations of methylprednisolone acetate, triamcinolone acetonide, and isoflupredone acetate on equine articular tissue cocultures in an inflammatory environment. Am. J. Vet. Res. 79(9), 933-940 (2018).
2. Ozone treatment for high-